Medical Science Liaison-(Los Angeles/San Diego)
Alnylam Pharmaceuticals
Summary
We are seeking an experienced Medical Science Liaison (MSL) to join the TTR team and support Alnylam's commitment to advancing the science and care of patients with transthyretin (TTR) amyloidosis. Patients often experience prolonged diagnostic journeys; this role is an opportunity to help elevate disease understanding and support evidence-based clinical decision-making through high-quality scientific exchange.
Job description
Overview
We are seeking an experienced Medical Science Liaison (MSL) to join the TTR team and support Alnylam's commitment to advancing the science and care of patients with transthyretin (TTR) amyloidosis. Patients often experience prolonged diagnostic journeys; this role is an opportunity to help elevate disease understanding and support evidence-based clinical decision-making through high-quality scientific exchange.
The MSL will be principally responsible for building and sustaining scientific partnerships with key opinion leaders (KOLs), investigators, and other healthcare professionals within an assigned geography. The MSL will identify and address unmet medical education needs, deliver balanced scientific information (including mechanism of action and emerging clinical data), and gather actionable medical insights to inform internal stakeholders.
This position partners closely with cross-functional colleagues (including Medical Affairs, Clinical Development, Market Access, and Patient Advocacy) to support strategic medical priorities for the TTR franchise and reports to the geographically aligned Field Medical Director. Must reside within the territory.
Key Responsibilities
- Partner closely with investigators and internal stakeholders to drive patient accrual.
- Identify key opinion leaders and cultivate a network of experts for key Alnylam disease areas.
- Develop, maintain, and execute US KOL and US Institution plans within respective geography.
- Conduct and implement a comprehensive disease awareness tactical plan within the respective geography.
- Collaborate with health care professionals to identify opportunities for the development of algorithms and guidelines to facilitate early diagnosis.
- Provide in-depth drug mechanism of action and emerging clinical information to health care providers in the respective geography.
- Serve as a liaison to health care professionals and professional organizations and disease state advocacy groups. Support the efforts of patient support groups and educational foundations.
- Provide medical and scientific input into the planning and execution of advisory boards and work with experts to review speaker presentations and provide additional medical background where requested.
- Contribute to Alnylam's achievement of Company objectives for pre-approved products.
- Provide educational meeting support at scientific congresses.
- Coordinate required medical, legal, and regulatory review and approval of all field documents for distribution or presentation.
- Require 60-70% travel.
Qualifications
- PhD, PharmD, DNP or MD with 3 to 5 years' industry experience.
- Proven clinical background to enable engagement of Health Care Professionals in a scientifically meaningful exchange.
- Prior experience in cardiology and rare disease strongly preferred.
- Experience in clinical research, patient recruitment, and investigator-sponsored trials.
- Experience in medical education and KOL management.
- Effective communication of evidence based scientific information.
- Ability to work collaboratively and cross-functionally.
- Capable of managing shifting priorities in a rapidly changing environment.
- Decision-making and accountability.
Requirements
- PhD, PharmD, DNP or MD
- 3 to 5 years' industry experience
- Proven clinical background to enable engagement of Health Care Professionals in a scientifically meaningful exchange
- Experience in clinical research, patient recruitment, and investigator-sponsored trials
- Experience in medical education and KOL management
- Effective communication of evidence based scientific information
- Ability to work collaboratively and cross-functionally
- Capable of managing shifting priorities in a rapidly changing environment
- Decision-making and accountability
- Prior experience in cardiology and rare disease strongly preferred
- Must reside within the territory
Benefits
- Medical Insurance
- Dental Insurance
- Vision Insurance
- Life Insurance
- Disability Insurance
- Lifestyle Reimbursement Program
- Flexible Spending Accounts
- Health Savings Accounts
- 401(k) With Company Match
- Paid Time Off
- Wellness Days
- Paid Holidays
- Company-Wide Recharge Breaks
- Family Resources
- Family Leave
- Annual Short-Term Incentive Award
- Annual Long-Term Incentive Award
Company overview
Alnylam Pharmaceuticals is a pioneering American biopharmaceutical company and the global leader in RNA interference (RNAi) therapeutics. Founded in 2002 and headquartered in Cambridge, Massachusetts, Alnylam has revolutionized the field of genetic medicine by developing innovative treatments that 'silence' disease-causing genes. The company achieved a historic milestone in 2018 with the approval of Onpattro (patisiran), the world's first RNAi therapeutic, which treats hereditary transthyretin-mediated amyloidosis. Since then, Alnylam has successfully commercialized five additional RNAi medicines targeting rare genetic disorders including acute hepatic porphyria, primary hyperoxaluria type 1, and transthyretin amyloidosis. With over 2,100 employees worldwide, Alnylam maintains a robust pipeline of investigational therapies across genetic medicines, cardiometabolic diseases, and hepatic infectious diseases. The company's groundbreaking work has established RNAi as a clinically validated therapeutic platform, earning recognition as one of the most innovative biopharmaceutical companies and consistently ranking as a top employer in the life sciences industry.